Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell T Wallin

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Neurology|August 26, 2020
Initial highly effective therapy for MS: A strong startMitchell T Wallin
Multiple Sclerosis and Related Disorders|June 9, 2016
In Memoriam: John F. Kurtzke, MD, FACP, FAAN 1926–2015Mitchell T Wallin
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 23, 2018
Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis - NoMitchell T Wallin
Journal of Rehabilitation Research and Development|August 31, 2010
Integrated multiple sclerosis care: new approaches and paradigm shiftsMitchell T Wallin
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 9, 2016
Tribute to John F. Kurtzke, MD, FACP, FAAN: 1926-2015Christopher T Bever, Mitchell T Wallin
Clinical Neurology and Neurosurgery|June 17, 2015
Presentation of multiple sclerosis with comorbid Huntington's diseaseHeidi W Maloni, Mitchell T Wallin
Neurology|November 10, 2004
Neurocysticercosis in the United States: review of an important emerging infectionMitchell T Wallin, John F Kurtzke
Neurology|December 26, 2014
Comorbidity increases the risk of hospitalizations in MS: prevention opportunitiesWilliam J Culpepper, Mitchell T Wallin
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Multidisciplinary Management of a Patient With Multiple Sclerosis: Part 1. Neurologists' and Physiatrists' PerspectivesMitchell T Wallin, Scott Campea, Jodie K Haselkorn
Journal of Rehabilitation Research and Development|July 19, 2006
Cognitive dysfunction in multiple sclerosis: Assessment, imaging, and risk factorsMitchell T Wallin, Jeffrey A Wilken, Robert Kane
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Neurology|August 26, 2020
Initial highly effective therapy for MS: A strong startMitchell T Wallin
Multiple Sclerosis and Related Disorders|June 9, 2016
In Memoriam: John F. Kurtzke, MD, FACP, FAAN 1926–2015Mitchell T Wallin
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 23, 2018
Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis - NoMitchell T Wallin
Journal of Rehabilitation Research and Development|August 31, 2010
Integrated multiple sclerosis care: new approaches and paradigm shiftsMitchell T Wallin
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 9, 2016
Tribute to John F. Kurtzke, MD, FACP, FAAN: 1926-2015Christopher T Bever, Mitchell T Wallin
Clinical Neurology and Neurosurgery|June 17, 2015
Presentation of multiple sclerosis with comorbid Huntington's diseaseHeidi W Maloni, Mitchell T Wallin
Neurology|November 10, 2004
Neurocysticercosis in the United States: review of an important emerging infectionMitchell T Wallin, John F Kurtzke
Neurology|December 26, 2014
Comorbidity increases the risk of hospitalizations in MS: prevention opportunitiesWilliam J Culpepper, Mitchell T Wallin
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Multidisciplinary Management of a Patient With Multiple Sclerosis: Part 1. Neurologists' and Physiatrists' PerspectivesMitchell T Wallin, Scott Campea, Jodie K Haselkorn
Journal of Rehabilitation Research and Development|July 19, 2006
Cognitive dysfunction in multiple sclerosis: Assessment, imaging, and risk factorsMitchell T Wallin, Jeffrey A Wilken, Robert Kane
Pageof 6